The table below shows agilon health, inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$23.73M
-$31.99M
-$47.78M
-$60.81M
-$23.23M
-$40.83M
Capital expenditure
$3.10M
$3.85M
$3.14M
$3.72M
$4.05M
$178.00K
Investing cash flow
$19.27M
-$23.09M
$51.44M
-$50.81M
-$8.87M
-$9.07M
Dividends paid
-
-
-
-
AGL operating cash flow (10-K history)
agilon health, inc. reported operating cash flow of -$105.76M for fiscal year 2025. That is down 83.1% from -$57.78M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$103.86M (FY 2019) to -$105.76M. Figures come from the company's audited annual reports as filed with the SEC.
